Market Access Innovation beyond invention will bring novel medicines to Eu... Unlocking the potential of novel medicines for Europe’s patients demands innovation beyond invention.
Sales & Marketing Sunshine transparency reporting for emerging pharma: Simplif... Pharmaceutical and medical device manufacturers launching their first product in the US face several complex challenges while preparing for the required collection and reporting of transfer
News FDA won't approve Summit, Akeso's ivonescimab The FDA has said it cannot approve Summit /Akeso's ivonescimab, delaying a drug that could usher in a new era of dual-acting cancer immunotherapies.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
